Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Schrodinger Inc (SDGR)

Schrodinger Inc (SDGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,746,339
  • Shares Outstanding, K 73,038
  • Annual Sales, $ 207,540 K
  • Annual Income, $ -187,120 K
  • EBIT $ -209 M
  • EBITDA $ -203 M
  • 60-Month Beta 1.84
  • Price/Sales 8.40
  • Price/Cash Flow N/A
  • Price/Book 4.67

Options Overview Details

View History
  • Implied Volatility 69.37% ( -7.43%)
  • Historical Volatility 90.36%
  • IV Percentile 60%
  • IV Rank 41.79%
  • IV High 98.58% on 04/08/25
  • IV Low 48.41% on 05/17/24
  • Put/Call Vol Ratio 0.56
  • Today's Volume 886
  • Volume Avg (30-Day) 1,505
  • Put/Call OI Ratio 0.27
  • Today's Open Interest 36,897
  • Open Int (30-Day) 31,910

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.84
  • Number of Estimates 3
  • High Estimate -0.73
  • Low Estimate -1.07
  • Prior Year -0.74
  • Growth Rate Est. (year over year) -13.51%

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.69 +6.53%
on 05/08/25
27.27 -11.37%
on 04/23/25
-0.32 (-1.31%)
since 04/11/25
3-Month
16.60 +45.60%
on 04/07/25
28.47 -15.10%
on 02/18/25
+0.31 (+1.30%)
since 02/12/25
52-Week
16.60 +45.60%
on 04/07/25
28.47 -15.10%
on 02/18/25
+1.44 (+6.34%)
since 05/10/24

Most Recent Stories

More News
AI Healthcare Boom Gains Speed as Regulators and Innovators Align

/CNW/ --The integration of artificial intelligence (AI) into healthcare is here to stay, and adoption is accelerating. According to research from PYMNTS...

AVAI : 0.5200 (+5.05%)
GEHC : 74.11 (+6.07%)
SDGR : 24.17 (+1.09%)
TEM : 62.69 (+2.15%)
TVGN : 1.1900 (+9.17%)
3 Momentum Stocks That Could Soar Post-Market Volatility

Three unexpected companies have rallied quickly in the period following tariff-related market turbulence; can they maintain momentum?

LOVE : 20.91 (+4.03%)
SDGR : 24.17 (+1.09%)
NVS : 108.95 (+0.23%)
CERT : 12.13 (+1.25%)
Healthcare AI Market to Surge 43% Annually—Key Stocks to Watch

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group News Commentary – The integration of artificial intelligence (AI) into the healthcare sector is accelerating at an unprecedented...

AVAI : 0.5200 (+5.05%)
ABSI : 2.93 (+6.55%)
SDGR : 24.17 (+1.09%)
MDAI : 1.3600 (+9.68%)
MDT : 85.81 (+2.79%)
AI Pharma: 2 Paths to AI-Powered Drug Investment

AI is transforming drug development, allowing companies to identify new drug targets, optimize clinical trials and speed delivery of medicines to patients.

LLY : 755.57 (+2.86%)
GPCR : 24.62 (-3.72%)
SDGR : 24.17 (+1.09%)
NVS : 108.95 (+0.23%)
RXRX : 4.64 (+7.16%)
Health AI Revolution: Experts Predict Major Advancements in AI-Powered Healthcare in 2025

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group News Commentary – Experts predict that artificial intelligence (AI) will soon transition from a novel concept in healthcare...

AVAI : 0.5200 (+5.05%)
GEHC : 74.11 (+6.07%)
SDGR : 24.17 (+1.09%)
MDAI : 1.3600 (+9.68%)
TEM : 62.69 (+2.15%)
3 Small-Cap Stocks to Invest in AI Drug Development

As AI continues to reshape the drug development landscape, here are three promising small-cap biotech stocks worth considering now.

NVDA : 123.00 (+5.44%)
RXRX : 4.64 (+7.16%)
SDGR : 24.17 (+1.09%)
EXAI : 4.84 (+3.20%)
What's the Difference Between Biotech Stocks and TechBio Stocks?

A few enterprising businesses are marketing themselves differently.

DNA : 8.31 (+7.09%)
RXRX : 4.64 (+7.16%)
SDGR : 24.17 (+1.09%)
6 Under-the-Radar AI Stocks That Analysts Expect to Rally

Morgan Stanley is betting on these stocks to benefit from the AI megatrend.

MSFT : 449.26 (+2.40%)
NVDA : 123.00 (+5.44%)
DH : 3.58 (-2.98%)
SRAD : 23.16 (+0.39%)
MS : 127.06 (+4.40%)
SPGI : 518.36 (+2.09%)
RXRX : 4.64 (+7.16%)
SDGR : 24.17 (+1.09%)
RBLX : 73.49 (+2.24%)
AMZN : 208.64 (+8.07%)
Billionaire Bill Gates Has 35% of His Portfolio Invested in These 2 Artificial Intelligence (AI) Stocks: Are They No-Brainer Buys?

AI is a key growth driver for both of these stocks owned by the Gates Foundation Trust.

MSFT : 449.26 (+2.40%)
SDGR : 24.17 (+1.09%)
3 AI-Driven Drug Stocks to Buy Before They Breakout

The pharma sector is expected to undergo a huge disruption, thanks to the impact of artificial intelligence. Here are three companies that Wall Street analysts think could benefit, based on their AI-driven...

NVDA : 123.00 (+5.44%)
GOOGL : 158.46 (+3.74%)
ABCL : 2.06 (+1.48%)
LLY : 755.57 (+2.86%)
ABSI : 2.93 (+6.55%)
NVS : 108.95 (+0.23%)
SDGR : 24.17 (+1.09%)
GS : 591.34 (+4.27%)
REGN : 575.63 (+9.07%)
MRNA : 25.70 (+5.98%)
AMZN : 208.64 (+8.07%)
BMY : 48.18 (+3.72%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Schr'dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr'dinger Inc. is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 25.88
2nd Resistance Point 25.27
1st Resistance Point 24.72
Last Price 24.17
1st Support Level 23.56
2nd Support Level 22.95
3rd Support Level 22.40

See More

52-Week High 28.47
Last Price 24.17
Fibonacci 61.8% 23.94
Fibonacci 50% 22.53
Fibonacci 38.2% 21.13
52-Week Low 16.60

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar